文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

肝素联合DNase I治疗脓毒症小鼠心肌损伤

HEPARIN AND DNase I TREAT MYOCARDIAL INJURY IN SEPTIC MICE.
PubMed 文献 · Shock · 2025-03-03
一句话结论脓毒症小鼠中单用普通肝素加重心肌损伤,普通肝素联合DNase I可减轻心肌损伤并抑制NETs形成与炎症。

该研究在盲肠结扎穿刺(CLP)诱导的C57BL/6脓毒症小鼠模型中,观察普通肝素(UFH)、UFH联合DNase I及引入NETs对心肌损伤的影响。结果显示单用UFH增加NETs形成、上调TNF-α和IL-6、升高CK-MB和LDH,加重心肌损伤;UFH联合DNase I显著减轻心肌损伤,抑制NETs形成和炎症。蛋白组学分析识别出与NETs、代谢及补体和凝血级联相关的关键通路,Ccn1和Tagln被突出为潜在治疗靶点。作者认为该研究可能为脓毒症患者早期使用肝素提供新见解和选择,尤其是心肌损伤风险较高的病例。

要点

  • 在CLP诱导的脓毒症小鼠中,单用UFH治疗增加NETs形成、上调TNF-α和IL-6、升高CK-MB和LDH,加重心肌损伤。
  • UFH联合DNase I在脓毒症小鼠中显著减轻心肌损伤,抑制NETs形成和炎症。
  • 蛋白组学分析识别出与NETs、代谢及补体和凝血级联相关的关键通路,Ccn1和Tagln被突出为潜在治疗靶点。
  • 作者认为该研究可能为脓毒症患者早期使用肝素提供新见解和选择,尤其适用于心肌损伤风险较高的病例。

适用人群与场景

  • CLP诱导的脓毒症C57BL/6小鼠模型,用于研究心肌损伤。

处置流程与药物剂量

  • 实验分组包括UFH治疗、UFH联合DNase I治疗以及引入NETs。
  • 心肌损伤评估采用苏木精-伊红染色、酶联免疫吸附测定检测损伤标志物(CK-MB和LDH)以及Western blotting检测炎症蛋白(TNF-α和IL-6)。
  • 采用数据独立采集质谱进行差异蛋白组学分析,并行通路富集分析(Gene Ontology和Kyoto Encyclopedia of Genes and Genomes)以识别受治疗影响的分子通路和关键蛋白。

研究设计与关键结果

  • 研究类型为动物实验(脓毒症小鼠模型),样本为C57BL/6小鼠,建立CLP诱导的脓毒症模型。
  • 单用UFH治疗增加NETs形成、上调TNF-α和IL-6、升高CK-MB和LDH,加重心肌损伤。
  • UFH联合DNase I显著减轻心肌损伤,抑制NETs形成和炎症。
  • 蛋白组学分析识别出与NETs、代谢及补体和凝血级联相关的关键通路,Ccn1和Tagln被突出为潜在治疗靶点。

证据类型、等级与局限

  • 证据类型:动物实验(脓毒症小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该研究可能为脓毒症患者早期使用肝素提供新见解和选择,尤其是心肌损伤风险较高的病例。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Sepsis is a life-threatening clinical condition often seen in intensive care units, leading to multi-organ dysfunction. Myocardial injury is a prevalent complication, significantly increasing mortality among sepsis patients. Although heparin is used in sepsis management, its specific effects on myocardial injury and the role of neutrophil extracellular traps (NETs) in this context remain insufficiently understood. Aim: This study investigates the role of unfractionated heparin (UFH) combined with DNase I in reducing myocardial injury in a septic mouse model. Methods: A cecal ligation and puncture (CLP)-induced sepsis model was established in C57BL/6 mice to study myocardial injury. The experimental groups included treatments with UFH, UFH with DNase I, and NETs introduction. Myocardial injury was assessed using hematoxylin and eosin staining, enzyme linked immunosorbent assay for injury markers (creatine kinase MB [CK-MB] and lactate dehydrogenase [LDH]), and Western blotting for inflammatory proteins (TNF-α and IL-6). Differential proteomic analysis using data independent acquisition mass spectrometry and pathway enrichment analysis (Gene Ontology and Kyoto Encyclopedia of Genes and Genomes) were conducted to identify molecular pathways and key proteins affected by the treatments. Results: Single UFH treatment increased the formation of NETs, upregulated TNF-α and IL-6, and increased CK-MB and LDH, worsening myocardial injury. The combination of UFH and DNase I significantly reduced myocardial injury, suppressing NETs formation and inflammation. Proteomic analysis identified crucial pathways related to NETs, metabolism, and complement and coagulation cascades, with proteins Ccn1 and Tagln highlighted as potential therapeutic targets. Conclusion: UFH combined with DNase I effectively alleviates myocardial injury in septic mice by modulating NETs formation and associated inflammatory processes. This study may provide new insights and options for the early use of heparin in the treatment of septic patients, particularly in cases with a higher risk of myocardial injury.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wang D, Hei Y, Sun H, et al. HEPARIN AND DNase I TREAT MYOCARDIAL INJURY IN SEPTIC MICE. Shock. 2025. PMID: 40138729. doi:10.1097/SHK.0000000000002566

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。